Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.12 | $15.36 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,359 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:15 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $5.17 | $5,170.00 |
DisclosureSEC source: 0001628280-25-013548 · wk-form4_1742332542.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,318 F1 · shares: Restricted stock award will vest 100% on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.41 | $16.23 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,356 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 14, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.38 | $16.14 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,353 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 13, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.47 | $16.41 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,350 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 12, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.17 | $15.51 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,347 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 11, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $4.85 | $14.55 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,344 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 10, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 3 | $5.85 | $17.55 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,341 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 07, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $6.51 | $26.04 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,338 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 06, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $6.57 | $26.28 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,334 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 05, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $6.75 | $27.00 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,330 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 04, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.11 | $20.44 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,326 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 03, 2025 Filed Apr 4, 2025 17:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.54 | $22.16 |
DisclosureSEC source: 0001628280-25-016745 · wk-form4_1743788280.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,322 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 20, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 2 | $2.35 | $4.70 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,818 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 19, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $2.33 | $9.32 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,816 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 18, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $2.19 | $21.90 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,812 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 17, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $2.12 | $21.20 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,802 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 16, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $2.21 | $22.10 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,792 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 13, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $2.33 | $16.31 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,782 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 12, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $2.19 | $15.33 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,775 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 11, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $2.29 | $16.03 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,768 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 10, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $2.48 | $17.36 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,761 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 09, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.25 | $18.75 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,754 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 06, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.20 | $18.00 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,739 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 05, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.20 | $18.00 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,724 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 04, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.22 | $18.30 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,709 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 03, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.26 | $18.90 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,694 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 02, 2024 Filed Dec 31, 2024 00:47 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $1.33 | $19.95 |
DisclosureSEC source: 0001628280-24-052610 · wk-form4_1735606056.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,679 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 29, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $1.32 | $21.12 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,664 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 27, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $1.15 | $18.40 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,648 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 26, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $1.09 | $17.44 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,632 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 25, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $1.09 | $17.44 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,616 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 22, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $1.07 | $17.12 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,600 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 21, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 43 | $1.09 | $46.87 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,584 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 20, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 43 | $1.13 | $48.59 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,541 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 19, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.15 | $43.70 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,498 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 18, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.18 | $44.84 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,460 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 15, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.17 | $44.46 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,422 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 14, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.19 | $45.22 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,384 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 13, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.20 | $45.60 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,346 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 12, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.20 | $45.60 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,308 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 11, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.20 | $45.60 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,270 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 08, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.18 | $44.84 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,232 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 07, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.17 | $44.46 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,194 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 06, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.20 | $45.60 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,156 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 05, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.20 | $45.60 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,118 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 04, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 25 | $1.17 | $29.25 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,080 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 01, 2024 Filed Dec 5, 2024 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 38 | $1.15 | $43.70 |
DisclosureSEC source: 0001628280-24-050113 · wk-form4_1733436307.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,055 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 31, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.20 | $37.20 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 23 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,017 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 30, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.32 | $40.92 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,986 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.